Marion Wealth Management Purchases 163 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Marion Wealth Management raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 5,132 shares of the healthcare conglomerate’s stock after acquiring an additional 163 shares during the quarter. Marion Wealth Management’s holdings in UnitedHealth Group were worth $3,001,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. MBM Wealth Consultants LLC lifted its stake in shares of UnitedHealth Group by 4.7% in the third quarter. MBM Wealth Consultants LLC now owns 2,812 shares of the healthcare conglomerate’s stock worth $1,644,000 after acquiring an additional 126 shares during the period. Blue Zone Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 2.2% in the 3rd quarter. Blue Zone Wealth Advisors LLC now owns 10,797 shares of the healthcare conglomerate’s stock valued at $6,313,000 after purchasing an additional 235 shares during the last quarter. Skyline Advisors Inc. boosted its position in UnitedHealth Group by 9.0% during the third quarter. Skyline Advisors Inc. now owns 557 shares of the healthcare conglomerate’s stock valued at $326,000 after acquiring an additional 46 shares during the last quarter. Callan Family Office LLC increased its position in shares of UnitedHealth Group by 39.5% during the third quarter. Callan Family Office LLC now owns 3,398 shares of the healthcare conglomerate’s stock worth $1,987,000 after acquiring an additional 963 shares in the last quarter. Finally, Aprio Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 18.4% in the 3rd quarter. Aprio Wealth Management LLC now owns 1,154 shares of the healthcare conglomerate’s stock worth $675,000 after buying an additional 179 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $583.56 on Tuesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The firm has a market cap of $537.10 billion, a PE ratio of 35.67, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The firm’s 50 day simple moving average is $582.24 and its 200-day simple moving average is $527.84. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.14 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is presently 51.34%.

Analysts Set New Price Targets

Several brokerages recently weighed in on UNH. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. HSBC raised their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Argus boosted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Morgan Stanley upped their target price on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Finally, Barclays boosted their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.